CN1045893C - Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. - Google Patents
Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. Download PDFInfo
- Publication number
- CN1045893C CN1045893C CN93117115A CN93117115A CN1045893C CN 1045893 C CN1045893 C CN 1045893C CN 93117115 A CN93117115 A CN 93117115A CN 93117115 A CN93117115 A CN 93117115A CN 1045893 C CN1045893 C CN 1045893C
- Authority
- CN
- China
- Prior art keywords
- medicine
- hysteromyoma
- radix
- treatment
- hirudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a patent medicine formula for treating female hysteromyoma, which is prepared from oldenlandia as a main medicine and 16 natural Chinese herbal medicines such as ark shell, leech, milkvetch root, etc. The manufacturing technology of the patent medicine of the present invention is the same as that of the common Chinese medicinal patent medicine. The medicine of the present invention can effectively suppress the growth of hysteromyoma and prompt hysteromyoma to soften, shrink until disappear; the medicine has no side effect.
Description
The present invention relates to a kind of medicine of specially controlling hysteromyoma, is main by Herba Hedyotidis Diffusae (abbreviation Herba Hedyotidis Diffusae) promptly, cooperates the patent medicine of 16 kinds of Chinese medicines such as Concha Arcae, Hirudo, the Radix Astragali and medical herbs preparation.
Leiomyoma of uterus is a common gynecological disease, frequently-occurring disease, and the patient often follows more or heavier clinical symptoms, and its menoxenia is infertile, secondary anemia, spontaneous abortion very then cancerates etc., serious harm women's physical and mental health.Western medical treatment mainly is an excision at present, operation brings great misery to patient, some patient (as unmarried or married nullipara woman) therefore loses fertility, and the conservative operation is because limitation also can't be effected a radical cure muscular tumor, so general patient is reluctant to be treated surgically.The LHRH synergist that doctor trained in Western medicine is adopted aspect medicine, tamoxifen, gossypol, vitamin etc. are treated, and in fact these medicines can only be as auxiliary treatment or indirectly treatment, and can only suppress the growth of hysteromyoma to a certain extent, can't effect a radical cure.And behind these drug administrations liver, renal function there are certain infringement, and can cause side effect such as degrees of osteoporotic, atherosclerosis, take for a long time also and can produce drug resistance.The existing quite long history of Chinese traditional treatment hysteromyoma, but still do not have effective Chinese patent medicine only depends on the doctor to make up a prescription according to patient's practical situation evolution and treats.The general treatment time, most patients reached two, three years the course of treatment, and obvious effective rate is low all more than three months.This do not have a set form, depends on doctor's the technical merit itself and the Therapeutic Method of practical experience, only depends on the introduction of clinical experience on applying, and can't popularize.
The purpose of this invention is to provide and effect a radical cure hysteromyoma in a short time effectively after a kind of confession extensive patients is taken, and the patent medicine that natural Chinese medicines that has no side effect and medical herbs are mixed with.
For this reason, medicine of the present invention adopts based on Herba Hedyotidis Diffusae, cooperates the patent medicine of 16 kinds of Chinese medicines such as Concha Arcae, Hirudo, the Radix Astragali and medical herbs preparation, and its medicine name and proportioning consumption are as follows:
Herba Hedyotidis Diffusae 16%, Radix Salviae Miltiorrhizae 9%, the Radix Astragali 8%, Concha Arcae 8.5%, Radix Paeoniae Rubra 8.5%, Poria 7%, Sargassum 6%, Thallus Laminariae (Thallus Eckloniae) 6%, Radix Bupleuri 5%, Spica Prunellae 5%, Endothelium corneum 5%, Semen Vaccariae 5%, Radix Angelicae Sinensis 5%, Fructus Aurantii Immaturus 4%, Hirudo 0.5%, Radix Glycyrrhizae 1.5%.
Medicine of the present invention is made up of the Chinese medicine and the medical herbs of three class difference in functionalitys.
1, soothing the liver circulation of qi promoting, blood circulation promoting and blood stasis dispelling
Radix Bupleuri, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Vaccariae, Hirudo, six kinds of medicines of Fructus Aurantii Immaturus, pharmacology and clinical proof, this class medicine circulation of qi promoting effect and blood stasis dispelling effect are collaborative mutually, wherein invigorate blood circulation and be similar to anticoagulant, blood stasis dispelling is similar to fibrinolysis, so can impel proliferative lesion that in various degree softening arranged and absorb, thereby reach the growth that suppresses muscular tumor.
2, hard masses softening and resolving, the that disappears reduces phlegm
Herba Hedyotidis Diffusae, Sargassum, Spica Prunellae, Endothelium corneum, Thallus Laminariae (Thallus Eckloniae), six kinds of medicines of Concha Arcae, pharmacology and clinical proof, have to abolish and gather, dredge the meridian passage, the circulation QI and blood is recovered function, improve body antineoplastic function, and, disturb the existence of oncocyte or the external environment of change cell, thereby reach the purpose of dissipation muscular tumor by directly or indirectly effect.
3, benefiting QI and nourishing blood, spleen invigorating invigorating middle warmer
The Radix Astragali, Poria, Radix Glycyrrhizae, four kinds of medicines of Radix Angelicae Sinensis, its pharmacology and clinical proof contain bioactive polysaccharide, the energy activated T cell, and have the body immunity of raising, adjustment taste, strengthen the ability of digesting and assimilating, thereby make raising evident in efficacy medicine itself.
It is as follows that patent medicine of the present invention is implemented compound method:
Except that Hirudo, get the dried raw material of all the other medicines among the present invention by proportioning, smash to pieces respectively or chop up, the dried raw material of smashing to pieces or chopping up is added an amount of clear water respectively, soaked two hours.Follow these steps to then make:
1, get two kinds of medicament mixed of Herba Hedyotidis Diffusae, Concha Arcae of soaking respectively, and add clear water, make it cover powder, input decocts in the device and decocts earlier.Decoction process was closed steam for the steam of 100 ℃ of feedings after 30 minutes, be cooled to room temperature.
2, get the medicament mixed of all the other immersions, and add clear water, make it cover powder, drop into and decoct in the cooled decoction device mix homogeneously earlier.Feed 100 ℃ steam, closed steam through 90 minutes, cooling is left standstill 12 hours to room temperature.
3, leaching medicinal liquid makes slag liquid separately.
4, medicinal liquid is injected concentration tank, the control pH value is 5.0, and medicinal liquid is concentrated into every milliliter of amount that includes crude drug 0.8 gram.
5, the Hirudo usefulness of making a living by the proportioning dosage, is cleaned back low temperature and is dried, and pulverize behind disinfection by ultraviolet light, by the 0.5% proportioning branch capsule of packing into, is swallowed separately.So promptly produce medicine of the present invention.
Medicine of the present invention can be made confession patients such as becoming concentrated solution or soft gelatin capsule and take.
The present invention adopts the patent medicine of 16 kinds of natural Chinese medicines and medical herbs preparation, active ingredient is a side in its massive planting thing, animal, the mineral, adopt the method for reinforcement and elimination in combination, simultaneously using both cold and hot drugs, reach the motionless blood of blood stasis dispelling, assault fortified position and do not hinder positive purpose, use it can suppress the growth of hysteromyoma effectively, and impel it to soften, be contracted to disappearance, take in the process and have no side effect, and do not produce drug resistance.Use this Drug therapy, whole treatment only needs 60 days.
Medicine of the present invention is effective equally to gynecological's proliferative disease, as ovarian cyst, pelvic lump, nabothian cysts, ectopic pregnancy, chronic adnexitis, cyclomastopathy, endometriosis etc.
Claims (4)
1, a kind of medicine for the treatment of hysteromyoma is characterized in that being made by 16% Herba Hedyotidis Diffusae, 9% Radix Salviae Miltiorrhizae, 8% Radix Astragali, 8.5% Concha Arcae, 8.5% Radix Paeoniae Rubra, 7% Poria, 6% extra large bath, 6% Thallus Laminariae (Thallus Eckloniae), 5% Radix Bupleuri, 5% Spica Prunellae, 5% Endothelium corneum, 5% Semen Vaccariae, 5% Radix Angelicae Sinensis, 4% Fructus Aurantii Immaturus, 0.5% Hirudo, 1.5% Radix Glycyrrhizae.
2, a kind of medicine for the treatment of hysteromyoma according to claim 1, Herba Hedyotidis Diffusae, two kinds of medicines of Concha Arcae must mix back decoction earlier in patent medicine is made.
3, a kind of medicine for the treatment of hysteromyoma according to claim 1, the medicinal liquid that is made into be every milliliter of crude drug amount that should reach 0.8 gram after concentrating, and pH value is 5.0.
4, a kind of medicine for the treatment of the women according to claim 1 in the palace muscular tumor, the Hirudo usefulness of should making a living wherein, promptly low temperature dries the back pulverize, uses separately behind disinfection by ultraviolet light.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN93117115A CN1045893C (en) | 1993-05-15 | 1993-09-06 | Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN93105954 | 1993-05-15 | ||
CN93105954.2 | 1993-05-15 | ||
CN93117115A CN1045893C (en) | 1993-05-15 | 1993-09-06 | Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1100315A CN1100315A (en) | 1995-03-22 |
CN1045893C true CN1045893C (en) | 1999-10-27 |
Family
ID=25743034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93117115A Expired - Fee Related CN1045893C (en) | 1993-05-15 | 1993-09-06 | Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1045893C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100435841C (en) * | 2006-11-30 | 2008-11-26 | 灵宝市商业医院 | Medicament for treating phlebitis of mammary gland |
CN101249249B (en) * | 2008-03-24 | 2010-12-08 | 许文成 | Medicament for curing hysteromyoma, uterus, oviduct and ovary cyst and preparation |
CN105596620A (en) * | 2016-01-15 | 2016-05-25 | 张帆 | Chinese herbal medicine for treating miscellaneous gynecological diseases |
CN105770374A (en) * | 2016-04-12 | 2016-07-20 | 汤华淑 | Traditional Chinese medicine composition for treating uterine fibroid |
CN110548080A (en) * | 2019-10-09 | 2019-12-10 | 河南世豪医药科技有限公司 | Traditional Chinese medicine composition for treating mammary gland lobular hyperplasia and preparation method thereof |
-
1993
- 1993-09-06 CN CN93117115A patent/CN1045893C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《中国医药学报》1992,7(3) 1993. 3.31 刘雁峰中医药治疗子宫肌瘤近况 * |
《浙江中医杂志》1984,19(4) 1984. 4.30 杨升三,桂枝茯苓丸加减煎剂治疗子宫肌瘤100例总结 * |
《浙江中医杂志》1984,19(4) 1984. 4.30 杨升三,桂枝茯苓丸加减煎剂治疗子宫肌瘤100例总结;《中国医药学报》1992,7(3) 1993. 3.31 刘雁峰中医药治疗子宫肌瘤近况 * |
Also Published As
Publication number | Publication date |
---|---|
CN1100315A (en) | 1995-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101391087B (en) | Medicine for treating placental retention of dairy cows after delivery | |
CN102512630A (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN101269157B (en) | Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain | |
CN1045893C (en) | Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. | |
CN101239134B (en) | Speckle-removing medicinal composition | |
CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
CN102357228B (en) | Traditional Chinese medicine combination for treating liver diseases | |
CN101129763A (en) | Chinese patent medicine for treating post partum hypogalactia | |
CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
CN1686227A (en) | Menstruation regulating powder | |
CN106620123A (en) | Wind dispelling and dampness eliminating selenium-enriched tea and preparation method thereof | |
CN102861292B (en) | Medicament for treating esophageal cancer and preparation method thereof | |
CN102526450B (en) | Chinese medicine composition for treating prostate disease | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN104524107A (en) | Chinese patent medicine for wind cold damp impediment symptom | |
CN109464640A (en) | Conditioning alopecia is lived again the edible medicine and preparation method thereof of blackening hair | |
CN102028887B (en) | Traditional Chinese medicine for treating hyperplasia of cervical vertebra | |
CN106727966A (en) | For treating Chinese medicine composition that waist-leg is ached and preparation method thereof | |
Xu et al. | Chinese herbal medicine | |
CN101537125B (en) | Chinese medicine for treating uterine cancer | |
CN106266704A (en) | The Chinese medicine composition for the treatment of gastroenteritis and preparation method | |
CN104721738A (en) | Traditional Chinese medicine preparation for treating nipple discharge and preparation method thereof | |
CN104398961A (en) | Traditional Chinese medicine preparation for treating viral hepatitis | |
CN104857191A (en) | Orally-taken drug for treating oviduct jam and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Jiu Xueying Document name: Notification of Termination of Patent Right |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |